Schulman 2009.

Methods	RCT comparing dabigatran versus warfarin in patients with acute venous thromboembolism.
Data	2564 patients were randomised (1274/1265, respectively in each treatment group).
Comparisons	Onsite assessment (local investigator blinded) versus assessment by an AC blinded to allocated treatment.
Outcomes	The primary selected was a composite outcome of symptomatic venous thromboembolism or related death. This was the study's primary outcome.
Notes
Risk of bias
Item	Authors' judgement	Description
Method for selecting cases to adjudicate?	No	All suspect events adjudicated were identified by onsite assessor who was blinded to allocated treatment.